Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bioinformatics strategies and biomarker refinement using high-throughput transcriptome data in transplantation.

Frontiers in bioinformatics·2026

Same author

British Red Squirrels (<i>S. vulgaris</i>) With Leprosy Develop Skeletal Lesions.

Interdisciplinary perspectives on infectious diseases·2026

Same author

Omics BioAnalytics: an RShiny application for multimodal biomarker panel discovery and assessment.

Bioinformatics advances·2026

Same author

Defining new Buruli ulcer endemic areas in urban southeastern Australia using bacterial genomics-informed possum excreta surveys.

Applied and environmental microbiology·2025

Same author

Cyclodextrin Counteracts Coxsackievirus-Induced Cardiac Damage by Protecting Desmosome Integrity and Suppressing Proinflammatory Cytokine Expression.

Microorganisms·2025

Same author

Anatomic approach to mitral isthmus ablation guided by left atrial intracardiac echocardiography.

Heart rhythm·2025

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Searching for 'omic' biomarkers.

David Lin¹, Zsuzsanna Hollander, Anna Meredith

¹NCE CECR Centre of Excellence for Prevention of Organ Failure.

The Canadian Journal of Cardiology

|June 13, 2009

Summary

The study discusses the need for new cardiovascular disease biomarkers. Advances in

Area of Science:

Biomarker Discovery
Cardiovascular Diseases
Personalized Medicine

Background:

Cardiovascular diseases (CVDs) present significant societal and economic challenges.
Current clinical indicators for CVD risk (e.g., blood pressure, cholesterol, obesity) have limitations.
There is a critical need for sensitive, specific, and minimally invasive biomarkers for personalized patient care.

Purpose of the Study:

To provide perspective on current strategies in cardiovascular biomarker development.
To discuss the potential limitations in the biomarker discovery and validation pathway.
To highlight the role of recent technological and regulatory advancements in accelerating biomarker implementation.

Main Methods:

Review of current biomarker development strategies.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Experiment Videos

Last Updated: Jun 22, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Analysis of regulatory frameworks (FDA, Health Canada) for 'omic' biomarkers.

Examination of ongoing Canadian biomarker studies.

Main Results:

The transition of cardiac biomarker discovery to clinical practice has historically been slow and unregulated.
Technological advancements and regulatory guidance are improving biomarker discovery and validation.
Canadian studies demonstrate potential for omics biomarkers in risk assessment, diagnosis, prognosis, and therapy response.

Conclusions:

Personalized healthcare for cardiovascular diseases requires novel, sensitive, and specific biomarkers.
Streamlined discovery and validation pathways, supported by regulatory bodies, are crucial for clinical uptake.
Ongoing research, particularly in Canada, showcases the potential of 'omic' biomarkers to revolutionize cardiovascular care.